| Literature DB >> 29226815 |
Nicolas Girerd1, Marie-France Seronde2, Stefano Coiro3, Tahar Chouihed4, Pascal Bilbault5, François Braun6, David Kenizou7, Bruno Maillier8, Pierre Nazeyrollas9, Gérard Roul10, Ludivine Fillieux11, William T Abraham12, James Januzzi13, Laurent Sebbag14, Faiez Zannad1, Alexandre Mebazaa15, Patrick Rossignol16.
Abstract
Congestion is one of the main predictors of poor patient outcome in patients with heart failure. However, congestion is difficult to assess, especially when symptoms are mild. Although numerous clinical scores, imaging tools, and biological tests are available to assist physicians in ascertaining and quantifying congestion, not all are appropriate for use in all stages of patient management. In recent years, multidisciplinary management in the community has become increasingly important to prevent heart failure hospitalizations. Electronic alert systems and communication platforms are emerging that could be used to facilitate patient home monitoring that identifies congestion from heart failure decompensation at an earlier stage. This paper describes the role of congestion detection methods at key stages of patient care: pre-admission, admission to the emergency department, in-hospital management, and lastly, discharge and continued monitoring in the community. The multidisciplinary working group, which consisted of cardiologists, emergency physicians, and a nephrologist with both clinical and research backgrounds, reviewed the current literature regarding the various scores, tools, and tests to detect and quantify congestion. This paper describes the role of each tool at key stages of patient care and discusses the advantages of telemedicine as a means of providing true integrated patient care.Entities:
Keywords: biomarkers; congestion; heart failure; lung ultrasound; natriuretic peptides; plasma volume
Mesh:
Substances:
Year: 2017 PMID: 29226815 DOI: 10.1016/j.jchf.2017.09.023
Source DB: PubMed Journal: JACC Heart Fail ISSN: 2213-1779 Impact factor: 12.035